A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation
Titel:
A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation
Auteur:
Rinaldi, David A. Kuhn, John G. Burris, Howard A. Dorr, F. Andrew Rodriguez, Gladys Eckhardt, S. Gail Jones, Suzanne Woodworth, James R. Baker, Sharyn Langley, Connie Mascorro, David Abrahams, Trent Von Hoff, Daniel D.